Methotrexate from Canada
Methotrexate is a folic acid antagonist featuring pteridine heterocyclic rings, used as an antineoplastic and immunosuppressant drug. It qualifies for HTS 2934.99.30.00 as an aromatic heterocyclic drug compound used in rheumatoid arthritis and cancer treatments.
Duty Rate — Canada → United States
16.5%
Rate breakdown
9903.05.2910%Section 301 (forced labor) — additional 10% ad valorem on products of Canada
Import Tips
• Submit Type II Drug Master Files and bioequivalence data for generic API approval during import clearance
• Provide impurity profiles and chiral purity certificates since it's a single enantiomer drug substance
• Include cytotoxic hazard labeling and UN shipping declarations for safe transport compliance